The AHA today voiced support for certain provisions in and proposed amendments to the Helping to End Addiction and Lessen (HEAL) Substance Use Disorders Act, which the Senate Finance Committee will begin marking up this afternoon. As introduced by Committee Chairman Orrin Hatch (R-UT), the legislation would require Medicare and Medicaid to provide beneficiaries better education, prevention, management and treatment options for pain and addiction; increase Medicare beneficiary awareness of non-opioid alternative treatments; increase treatment for substance use disorder; improve tracking of opioid prescriptions under Medicare Part D; expand and clarify Medicaid’s options for treating beneficiaries with substance use disorder; and improve data used to evaluate treatments for opioid use disorder. Finance Committee members have filed more than 50 amendments to the Chairman’s mark. The House of Representatives also has begun considering a number of opioid-related bills this afternoon, including four bills supported by the AHA.

Related News Articles

Headline
Thirty-three emerging hospital and health system leaders from 20 states will participate in the inaugural class of the AHA’s Next Generation Leaders Fellowship…
Headline
Community Health Improvement Week (June 1-5) celebrates people coming together to create healthier communities. And that's never been more important than now…
Headline
The National Academies of Sciences Engineering, and Medicine yesterday released recommendations for improving outcomes and metrics associated with four grant…
Headline
The AHA today debuted a new video that spotlights the value of membership in the AHA, including how the association is telling hospital and health systems’…
Headline
The Substance Abuse and Mental Health Services Administration Friday awarded $450 million in grants, including $250 million in emergency COVID-19 funding, to…
Headline
The AHA has been featured in numerous media publications, including the Washington Post, Wall Street Journal, Politico and Modern Healthcare, for various COVID…